ActeosideAlternative Names: TJC 160; Verbascoside
Latest Information Update: 22 Aug 2002
At a glance
- Originator Tsumura
- Class Antiallergics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Nephritis
Most Recent Events
- 22 Aug 2002 Discontinued for Nephritis in Japan (unspecified route)
- 08 Feb 2001 No-Development-Reported for Nephritis in Japan (Unknown route)